Drugs manufacturers in Ireland can expect fewer regulatory inspections of their manufacturing practices after a US regulator announced it is happy to rely on conclusions reached by Ireland’s Health Products Regulatory Authority (HPRA), a life sciences expert has said.
We understand Legal Issues in Asia